MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 80 filers reported holding MEI PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,000 | -75.3% | 63,485 | +10.2% | 0.00% | -100.0% |
| Q4 2021 | $154,000 | -6.1% | 57,612 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $164,000 | -5.2% | 59,336 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $173,000 | -21.0% | 60,746 | -5.0% | 0.00% | 0.0% |
| Q1 2021 | $219,000 | +30.4% | 63,921 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $168,000 | -13.0% | 63,752 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $193,000 | -26.1% | 61,779 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $261,000 | +169.1% | 63,183 | +5.3% | 0.00% | 0.0% |
| Q1 2020 | $97,000 | -11.0% | 59,983 | +36.0% | 0.00% | – |
| Q4 2019 | $109,000 | +51.4% | 44,089 | +2.5% | 0.00% | – |
| Q3 2019 | $72,000 | -33.9% | 43,032 | -0.7% | 0.00% | – |
| Q2 2019 | $109,000 | -99.9% | 43,332 | +428.2% | 0.00% | – |
| Q1 2014 | $91,299,000 | +42.4% | 8,203 | +2.5% | 0.00% | – |
| Q4 2013 | $64,128,000 | -12.2% | 8,006 | +24.3% | 0.00% | – |
| Q3 2013 | $73,030,000 | – | 6,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 600,000 | $1,074,000 | 0.22% |
| Iguana Healthcare Management, LLC | 150,000 | $269,000 | 0.11% |
| Endurant Capital Management LP | 95,438 | $171,000 | 0.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,568 | $1,437,000 | 0.05% |
| Opus Point Partners Management, LLC | 30,000 | $54,000 | 0.04% |
| Carnick & Kubik, LLC | 30,355 | $54,000 | 0.04% |
| GREAT POINT PARTNERS LLC | 52,254 | $94,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 296,491 | $531,000 | 0.02% |
| Ancora Advisors LLC | 0 | $146,000 | 0.02% |
| SIMPLEX TRADING, LLC | 70,249 | $125,000 | 0.02% |